use in starch processing to obtain modified starch with an increased number of
branch points and improved functional properties.
1.1
Genetic modification
Branching glycosyltransferase is manufactured
by pure culture fermentation
of a genetically modified strain of
Bacillus subtilis containing a synthetic gene coding
for branching glycosyltransferase from
Rhodothermus obamensis.
Bacillus
subtilis is a Gram-positive bacterium that is widely
distributed in nature and is
considered to be non-pathogenic and non-toxigenic. It has a long history of use in
the production of enzymes used in food processing,
including enzymes from
genetically engineered strains. It has also been granted a Qualified Presumption of
Safety status by the European Food Safety Authority (2008).
The gene encoding branching glycosyltransferase was originally cloned
from
R. obamensis, a thermophilic bacterium that
was isolated from a marine
hydrothermal vent. Based on the amino acid sequence of branching
glycosyltransferase translated from the
R. obamensis gene,
a synthetic gene was
designed that encodes branching glycosyltransferase with the same amino acid
sequence as that of the native
R. obamensis enzyme. The gene was subsequently
placed under deoxyribonucleic acid (DNA) regulatory
sequences derived from
several
Bacillus species and introduced into the
B. subtilis host strain JA1343 by
transformation. The chloramphenicol resistance gene (
cat) was used in
transformation
as a selectable marker, but it was subsequently deleted to make the
production strain marker free.
Chia sẻ với bạn bè của bạn: